(Q42209595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

main subject

prevention of HIV/AIDS

0 references

author

Irini Sereti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Christina C Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Martyn A. French

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

V Sheikh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

1 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

published in

Current HIV/AIDS reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

223-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24950732%20AND%20SRC:MED&resulttype=core&format=json

Integration of antiretroviral therapy with tuberculosis treatment

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Central nervous system immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Combination antifungal therapy for cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Determinants of survival in progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Depletion of regulatory T cells in HIV infection is associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Human immunodeficiency virus infection in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Hashimoto's thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Acute poststreptococcal glomerulonephritis: a manifestation of immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immune reconstitution inflammatory syndrome: immune restoration disease 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Pathology in euthermic bats with white nose syndrome suggests a natural manifestation of immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Mediators of Innate and Adaptive Immune Responses Differentially Affect Immune Restoration Disease Associated withMycobacterium tuberculosisin HIV Patients Beginning Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0213-0

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

21 January 2018

1 reference

12 December 2020

IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis

1 reference

12 December 2020

Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

1 reference

12 December 2020

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

1 reference

12 December 2020

Refractory polyarticular gouty arthritis as a manifestation of immune reconstitution inflammatory syndrome

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none

1 reference

12 December 2020

Acute gouty arthritis as a manifestation of immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy

1 reference

12 December 2020

Guillain‐Barre Syndrome Associated with Immune Reconstitution

1 reference

12 December 2020

Too much of a good thing? IRIS with natalizumab-associated PML

1 reference

12 December 2020